#Pharma #Bourse Bayer to Use Seattle Genetics Armed-Antibody Technology - Bloomberg http://t.co/SugaPXZcN4
June 26, 2013
Publicité
Bayer to Use Seattle Genetics Armed-Antibody Technology
Bayer AG (BAYN) will use Seattle Genetics Inc. (SGEN) 's armed antibody anti-cancer technology, seeking a foothold in a new class of drugs designed to be more effective and less destructive by ferrying chemotherapy straight into tumor cells.